Literature DB >> 18770277

Isolation and serological studies with infectious bursal disease viruses from fowl, turkeys and ducks: demonstration of a second serotype.

J B McFerran1, M S McNulty, E R McKillop, T J Connor, R M McCracken, D S Collins, G M Allan.   

Abstract

The isolation of a number of strains of infectious bursal disease (IBD) virus from fowl, turkeys and ducks is described. These isolates could be grouped into two serotypes using the neutralisation test. It is proposed that the cell culture adapted vaccine strain from fowl should be the prototype virus for serotype 1 and that the TY89 isolate from a turkey should be the prototype for serotype 2. The isolates in serotype 2 consisted of an antigenically homogeneous group of viruses from turkeys and fowl. However, within serotype 1, which represented isolates from fowl and ducks, some isolates showed only a 30% cross reaction with the vaccine strain. If cross protection mirrors cross neutralisation, then infection with viruses belonging to serotype 2 or with antigenically distant strains from serotype 1 provides one explanation for the apparent failure of the vaccine on certain sites. However, if cross protection does not mirror cross neutralisation, then a virus from serotype 2 could be used as a heterotypic vaccine for young birds with high levels of maternally derived antibody to serotype 1.

Entities:  

Year:  1980        PMID: 18770277     DOI: 10.1080/03079458008418423

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  47 in total

1.  Naturally occurring-neutralizing monoclonal antibody escape variants define the epidemiology of infectious bursal disease viruses in the United States.

Authors:  D B Snyder; V N Vakharia; P K Savage
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  Full-length sequence analysis of four IBDV strains with different pathogenicities.

Authors:  Daniel Petkov; Erich Linnemann; Darrell R Kapczynski; Holly S Sellers
Journal:  Virus Genes       Date:  2006-08-22       Impact factor: 2.332

3.  Identification and genetic analysis of infectious bursal disease viruses from field outbreaks in Kerala, India.

Authors:  D Nandhakumar; R Rajasekhar; G Logeshwaran; Chintu Ravishankar; Stephy Rose Sebastian; R Anoopraj; K Sumod; Binu K Mani; G Chaithra; Chandankar Vaidehi Deorao; Koshy John
Journal:  Trop Anim Health Prod       Date:  2019-11-08       Impact factor: 1.559

4.  Molecular determinants of virulence, cell tropism, and pathogenic phenotype of infectious bursal disease virus.

Authors:  M Brandt; K Yao; M Liu; R A Heckert; V N Vakharia
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Cloning and nucleotide analysis of segment A gene of infectious bursal disease virus detected in Korea.

Authors:  Toh-Kyung Kim; Sang-Geon Yeo
Journal:  Virus Genes       Date:  2003-01       Impact factor: 2.332

6.  Exchange of the C-terminal part of VP3 from very virulent infectious bursal disease virus results in an attenuated virus with a unique antigenic structure.

Authors:  Hein J Boot; A Agnes H M ter Huurne; Arjan J W Hoekman; Jan M Pol; Arno L J Gielkens; Ben P H Peeters
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Mapping of cross-reacting and serotype-specific epitopes on the VP3 structural protein of the infectious bursal disease virus (IBDV).

Authors:  G N Mahardika; H Becht
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

8.  Comparative susceptibility of chickens, turkeys and ducks to infectious bursal disease virus using immunohistochemistry.

Authors:  O A Oladele; D F Adene; T U Obi; H O Nottidge
Journal:  Vet Res Commun       Date:  2008-07-29       Impact factor: 2.459

9.  Biological roles of the major capsid proteins and relationships between the two existing serotypes of infectious bursal disease virus.

Authors:  S K Reddy; A Silim; M J Ratcliffe
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

10.  Epitope mapping of capsid proteins VP2 and VP3 of infectious bursal disease virus.

Authors:  T Yamaguchi; K Iwata; M Kobayashi; M Ogawa; H Fukushi; K Hirai
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.